Biomedical

The University of Alabama at Birmingham broke ground on the Altec/Styslinger Genomic Medicine and Data Sciences Building in April of 2022. Designed by Williams Blackstock Architects, the $78 million project involves the renovation and expansion of the existing Lyons-Harrison Research Building to accommodate leading-edge laboratories, computational suites, collaboration spaces, meeting rooms, and offices.

AbbVie opened a 480,000-sf biomedical research center in South San Francisco in April of 2022. Offering state-of-the-art laboratories and collaborative workspaces, the leased facility will accelerate the discovery and commercialization of new cancer therapeutics. As the anchor tenant for the Gateway of Pacific’s first phase of construction, AbbVie occupies 11 contiguous floors in the 12-story structure.

Mayo Clinic began construction in April of 2022 on the $134.6 million Integrated Education and Research Building in Phoenix. Designed CO Architects and DFDG Architecture, the 150,000-sf facility will house the College of Medicine and Science and its five schools: the Alix School of Medicine, the School of Graduate Medical Education, the School of Health Sciences, the School of Biomedical Sciences, and the School of Continuous Professional Development.

The University of Arkansas broke ground in April of 2022 on the Institute for Integrative & Innovative Research (I3R) in Fayetteville. Designed by HGA and Hufft, the $137.6 million facility will house five centers of excellence to drive discovery and commercialization in the overlapping fields of data science, food systems, materials science and engineering, integrative systems neuroscience, and metabolism bioscience and bioengineering.

EMD Serono completed construction in March of 2022 on the $70 million Horizon Building in Billerica, Mass. Designed by PM Group, the 149,000-sf structure provides collaborative research environments to accelerate the creation of specialty pharmaceuticals. The mixed-use R&D facility includes approximately 30,000 sf of flexible wet lab space featuring reconfigurable benches and overhead service panels with plug-and-play connectivity.

HYM Investment Group began construction in March of 2022 on a $280 million biomanufacturing hub in Revere, Mass. Designed by Elkus Manfredi Architects, the six-story life sciences facility will offer leasable research environments for biomedical and pharmaceutical companies. Complemented by retail and dining amenities, the structure will feature two double-height floors for GMP production and manufacturing activities.

Southern Research will begin construction in mid-2022 on an $84 million biotechnology center in Birmingham, Ala. Providing crucial biocontainment capacity for the study of infectious diseases, the 80,000-sf building will enhance pandemic preparedness efforts with BSL-3 laboratories spanning 7,500 sf. The five-level project will also include structural biology labs, high-throughput screening facilities, and a STEM education center.

Amgen broke ground in March of 2022 on a $550 million biomanufacturing center in Holly Springs, N.C. Accommodating the company's FleXBatch platform, the project will integrate traditional methods for drug substance production with single-use bioprocessing technologies to create a hybrid facility with unrivaled operational efficiencies. The next-generation plant will manufacture advanced therapeutics for the treatment of cardiovascular disease, cancer, osteoporosis, inflammation, and other conditions.

The University of Wyoming opened the $100 million Science Initiative Building in March of 2022 in Laramie. Designed by GSG Architecture and Perkins&Will, the 153,000-sf structure will enhance interaction among multiple disciplines by collocating researchers into a single complex with shared core facilities. Located on the first floor to mitigate vibration, the Center for Advanced Scientific Instrumentation provides electron microscopes, an X-ray refractometer, a mass spectrometer, and micro CT scanners.

Bristol Myers Squibb is partnering with Alexandria Real Estate Equities to create a 427,000-rsf R&D center in San Diego. Located in the Alexandria Point development, the leased facility will provide core labs for the creation of advanced biopharmaceutical therapies. Housing nearly 600 researchers and staff members, the collaborative building will consolidate employees from several regional campuses into a flexible working ecosystem for discovery and innovation.

Arizona State University completed construction in early 2022 on the $192 million Rob and Melani Walton Center for Planetary Health in Tempe. Designed by Architekton and Grimshaw, the 281,000-gsf facility provides leading-edge research labs for biological and life sciences, engineering, and sustainability, as well as offering dry labs for programs in computing, cybersecurity, and robotics.

Vermeulens has released its market outlook report for the fourth quarter of 2021. Key points include:

Eli Lilly & Company is investing approximately $700 million to create the Institute for Genetic Medicine in Boston. Located in the Seaport district, the leased facility will provide 334,000 rsf of leading-edge research space for the discovery of innovative RNA and DNA-based therapies. The project will also include a shared R&D center with dedicated and configurable lab environments to enable biotech start-ups to collaborate with Lilly scientists.

Build the first 14 floors now, then add a 16-story tower a decade or so into the future. That was Northwestern University’s unconventional approach to the construction of the Louis A. Simpson and Kimberly K. Querrey Biomedical Research Center on the Chicago campus of its Feinberg School of Medicine. It wasn’t the only out-of-the-box decision that enabled the university to move forward with its vision of creating a 1.2 million-sf, next-generation research hub about 10 miles south of its main campus in Evanston. Similarly inventive is the ownership arrangement of the first half, which became the largest academic biomedical research building in the U.S. when it opened in 2019. One of the medical school’s three major hospital affiliates, Ann and Robert H. Lurie Children’s Hospital of Chicago, owns four of the nine lab floors (amounting to roughly 160,000 sf) and has easements to four-ninths of all the common space in the 625,000-sf structure.

Piramal Pharma Solutions broke ground in February of 2022 on a £45 million antibody drug conjugate (ADC) facility in Grangemouth, Scotland. Accommodating both manufacturing and aseptic fill/finish operations, the structure will provide additional capacity for the creation of targeted cancer treatments and other innovative therapies. Representing an expansion of Piramal's existing ADC campus, the project is being delivered by Merit using its FlexiPOD V4.0 platform.